Table 3.
Demographic characteristics of patients with AP and COVID-19 in the peri-COVID group.
| Variable | Category | Peri-COVID n = 196 |
COVID-19 n = 28 |
Non-COVID-19 n = 168 |
p |
|---|---|---|---|---|---|
| Gender | Men | 91 (46.4%) | 19 (67.9%) | 72 (32.8%) | 0.017 * |
| Women | 105 (53.5%) | 9 (32.1%) | 96 (67.2%) | ||
| Age | Men | ||||
| mean ± SD Women |
62.19 ± 17.21 | 47 ± 15.61 | 66.19 ± 15.35 | <0.001 * | |
| mean ± SD | 65.55 ± 15.45 | 48.44 ± 20.71 | 67.16 ± 13.96 | <0.001 * | |
| Total | |||||
| mean ± SD | 63.99 ± 16.34 | 47.46 ± 17.03 | 66.74 ± 14.54 | <0.001 * | |
| Etiology | Biliary | 162 (82.6%) | 13 (46.4%) | 149 (88.7%) | <0.001 * |
| Alcohol | 22 (11.22%) | 8 (28.6%) | 14 (8.3%) | ||
| Unknown | 12 (6.12%) | 7 (25%) | 5 (3%) | ||
| Form | Mild | 39 (30.1%) | 3 (10.7%) | 117 (28.9%) | 0.040 * |
| Moderate | 98 (50%) | 13 (46.4%) | 171 (42.2%) | ||
| Severe | 59 (30.1%) | 12 (42.9%) | 117 (28.9%) | ||
| Hours_onset | 38.04 ± 26.34 | 41 ± 32.27 | 37.55 ± 25.30 | 0.594 | |
| Hosp_days | 11.37 ± 7.58 | 12.36 ± 8.89 | 11.21 ± 7.36 | 0.459 | |
| Complications | Abscess | 15 (7.7%) | 3 (10.7%) | 12 (7.1%) | 0.142 |
| Necrosis | 20 (10.2%) | 5 (17.9%) | 15 (8.9%) | ||
| Pseudocyst | 6 (3.1%) | 2 (7.1%) | 4 (2.4%) | ||
| Without | 155 (79.1%) | 18 (64.3%) | 137 (81.5%) | ||
| Treatment | Surgical | 10 (4.6%) | 1 (3.6%) | 9 (5.4%) | 0.693 |
| Medical | 186 (95.4%) | 27 (96.4%) | 159 (94.6%) | ||
| Mortality | Discharged | 36 (18.4%) | 12 (42.9%) | 24 (14.3%) | 0.007 * |
| Alive | 160 (81.6%) | 16 (57.1%) | 144 (85.7%) |
* p < 0.05—statistically significant. The p-value results from the comparison of the group of COVID-19 patients with the group of non-COVID-19 patients.